Posted in | News | Nanobusiness

Foresight Nanotech Appoints New President

Foresight Nanotech Institute has appointed Dr. Pearl Chin to the position of President. Dr. Chin brings to the organization her extensive experience in business consulting, operations, sales and marketing, and customer service, in diverse industries from small to large companies. Prior to joining Foresight Nanotech Institute, she was a management consultant with Pittiglio Rabin Todd & McGrath, optimizing Supply Chain operations. Before that, she headed domestic Customer Support under Sales and Marketing for TA Instruments, Inc.

Dr. Chin is a prolific writer on nanotechnology investing, business, management and social issues. She is actively sought out to speak about and be interviewed on diverse nanotechnology-related topics. She also has extensive research expertise, having done graduate research at NIST. Dr. Chin holds an MBA from Cornell University's Johnson Graduate School of Management, a Ph.D. in Materials Science from University of Delaware's Center for Composite Materials, and a Bachelor's Degree in Chemical Engineering from The Cooper Union in New York City.

Foresight Nanotech Institute was founded in 1986 to educate the public about nanotechnology. The Institute's 1st Conference on Molecular Nanotechnology preceded the signing of the National Nanotechnology Initiative by 10 years.

The prestigious Foresight Institute Feynman Prize in Nanotechnology has honored top nanotechnology research scientists since 1993.

"Dr. Chin's broad experience will be crucial in furthering Foresight's mission of promoting nanotech's benefits and heading off potential downsides," said Christine Peterson, Founder and Vice President of Foresight Nanotech Institute. "Our upcoming Technology Roadmap for Productive Nanosystems will benefit from both her technical and business background.

Her vision will guide Foresight in balancing our work on furthering research, educating the public, and contributing to improved public policy in nanotechnology." Peterson will remain with the organization as Vice President.
Link to Dr. Chin's Bio

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.